Skip to main content
Journal cover image

Priming with Adenovirus26 Vaccines Affects ALVAC-SIV/gp120 Vaccine Efficacy Tested in a SIVmac251 Challenge Model Performed One-Month Post-Vaccination

Publication ,  Conference
Gordon, SN; Vaccari, M; Doster, MN; Liyanage, NP; Pegu, P; Schifanella, L; Caccuri, F; Keele, BF; Foulds, KE; Shen, X; Tomaras, GD; Ferrari, G ...
Published in: AIDS RESEARCH AND HUMAN RETROVIRUSES
November 1, 2013

Duke Scholars

Published In

AIDS RESEARCH AND HUMAN RETROVIRUSES

EISSN

1931-8405

ISSN

0889-2229

Publication Date

November 1, 2013

Volume

29

Issue

11

Start / End Page

A39 / A39

Location

Barcelona, SPAIN

Publisher

MARY ANN LIEBERT, INC

Conference Name

Conference on AIDS Vaccine

Related Subject Headings

  • Virology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gordon, S. N., Vaccari, M., Doster, M. N., Liyanage, N. P., Pegu, P., Schifanella, L., … Franchini, G. (2013). Priming with Adenovirus26 Vaccines Affects ALVAC-SIV/gp120 Vaccine Efficacy Tested in a SIVmac251 Challenge Model Performed One-Month Post-Vaccination. In AIDS RESEARCH AND HUMAN RETROVIRUSES (Vol. 29, pp. A39–A39). Barcelona, SPAIN: MARY ANN LIEBERT, INC.
Gordon, S. N., M. Vaccari, M. N. Doster, N. P. Liyanage, P. Pegu, L. Schifanella, F. Caccuri, et al. “Priming with Adenovirus26 Vaccines Affects ALVAC-SIV/gp120 Vaccine Efficacy Tested in a SIVmac251 Challenge Model Performed One-Month Post-Vaccination.” In AIDS RESEARCH AND HUMAN RETROVIRUSES, 29:A39–A39. MARY ANN LIEBERT, INC, 2013.
Gordon SN, Vaccari M, Doster MN, Liyanage NP, Pegu P, Schifanella L, et al. Priming with Adenovirus26 Vaccines Affects ALVAC-SIV/gp120 Vaccine Efficacy Tested in a SIVmac251 Challenge Model Performed One-Month Post-Vaccination. In: AIDS RESEARCH AND HUMAN RETROVIRUSES. MARY ANN LIEBERT, INC; 2013. p. A39–A39.
Gordon, S. N., et al. “Priming with Adenovirus26 Vaccines Affects ALVAC-SIV/gp120 Vaccine Efficacy Tested in a SIVmac251 Challenge Model Performed One-Month Post-Vaccination.” AIDS RESEARCH AND HUMAN RETROVIRUSES, vol. 29, no. 11, MARY ANN LIEBERT, INC, 2013, pp. A39–A39.
Gordon SN, Vaccari M, Doster MN, Liyanage NP, Pegu P, Schifanella L, Caccuri F, Keele BF, Foulds KE, Shen X, Tomaras GD, Montefiori DC, Roederer M, Ferrari G, Venzon D, Stablien D, Barouch DH, Felber BK, Pavlakis GN, Michael NL, Tartaglia J, Franchini G. Priming with Adenovirus26 Vaccines Affects ALVAC-SIV/gp120 Vaccine Efficacy Tested in a SIVmac251 Challenge Model Performed One-Month Post-Vaccination. AIDS RESEARCH AND HUMAN RETROVIRUSES. MARY ANN LIEBERT, INC; 2013. p. A39–A39.
Journal cover image

Published In

AIDS RESEARCH AND HUMAN RETROVIRUSES

EISSN

1931-8405

ISSN

0889-2229

Publication Date

November 1, 2013

Volume

29

Issue

11

Start / End Page

A39 / A39

Location

Barcelona, SPAIN

Publisher

MARY ANN LIEBERT, INC

Conference Name

Conference on AIDS Vaccine

Related Subject Headings

  • Virology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences